Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Blood|June 6, 2012
Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferationMi Cai, Ellen M Langer, Jennifer G Gill, et al.Plos One|December 1, 2017
The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine modelMahnaz Janghorban, Ellen M Langer, Xiaoyan Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancerMahnaz Janghorban, Amy S Farrell, Brittany L Allen-Petersen, et al.Cell Stem Cell|July 3, 2008
Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCsR Coleman Lindsley, Jennifer G Gill, Theresa L Murphy, et al.Cell Reports|January 1, 2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancerKaylyn L Devlin, Rebecca Smith, Elmar Bucher, et al.Cell|October 10, 2002
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damageBenjamin E Deverman, Brian L Cook, Scott R Manson, et al.Nature Reviews Bioengineering|February 20, 2026
Synthetic living materials in cancer biologyShelly R Peyton, Lesley W Chow, Stacey D Finley, et al.The Journal of Clinical Investigation|November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneityTyler Risom, Xiaoyan Wang, Juan Liang, et al.Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.Cell Reports|January 17, 2019
Modeling Tumor Phenotypes In Vitro with Three-Dimensional BioprintingEllen M Langer, Brittany L Allen-Petersen, Shelby M King, et al.Pageof 3